- Presentations
- 3
- Markets
- 1
Lumakras is a brand of Sotorasib marketed by Amgen, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sotorasib
- Brand owner
- Amgen
- Registered in
- United States
- Strengths and forms
- 120 mg tablet, 240 mg tablet, 320 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Lumakras 120 mg tabletOral | Amgen | US FDA | Available on request |
| Lumakras 240 mg tabletOral | Amgen | US FDA | Available on request |
| Lumakras 320 mg tabletOral | Amgen | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Lumakras
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.